Sorafenib triggers antiproliferative and pro-apoptotic signals in human esophageal adenocarcinoma cells. [electronic resource]
Producer: 20090203Description: 3055-64 p. digitalISSN:- 0163-2116
- Adenocarcinoma -- drug therapy
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Benzenesulfonates -- pharmacology
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cyclin D1 -- metabolism
- Cyclin E -- metabolism
- Esophageal Neoplasms -- drug therapy
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Humans
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Proto-Oncogene Proteins c-akt -- metabolism
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Proto-Oncogene Proteins c-myc -- metabolism
- Pyridines -- pharmacology
- STAT3 Transcription Factor -- metabolism
- Sorafenib
- p38 Mitogen-Activated Protein Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.